94 related articles for article (PubMed ID: 6264367)
1. Immunologic detection of occult primary cancer of the head and neck.
Neel HB; Pearson GR; Weiland LH; Taylor WF; Goepfert HH
Otolaryngol Head Neck Surg; 1981; 89(2):230-4. PubMed ID: 6264367
[TBL] [Abstract][Full Text] [Related]
2. The significance of serologic test for EB-virus antibody in occult type nasopharyngeal carcinoma.
Furukawa M; Takimoto T; Morishita K; Komori T; Ishiguro H; Umeda R
Auris Nasus Larynx; 1983; 10(1):43-8. PubMed ID: 6311149
[TBL] [Abstract][Full Text] [Related]
3. Anti-EBV serologic tests for nasopharyngeal carcinoma.
Neel HB; Pearson GR; Weiland LH; Taylor WF; Goepfert HH; Pilch BZ; Lanier AP; Huang AT; Hyams VJ; Levine PH; Henle G; Henle W
Laryngoscope; 1980 Dec; 90(12):1981-90. PubMed ID: 6256597
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to herpes group viruses in patients with nasopharyngeal and other head and neck cancers.
Henderson BE; Louie E; Bogdanoff E; Henie W; Alena B; Henie G
Cancer Res; 1974 May; 34(5):1207-10. PubMed ID: 4366990
[No Abstract] [Full Text] [Related]
5. Nasopharyngeal carcinoma (NPC). VI. Presence of an EBV nuclear antigen in fresh tumour biopsies. Preliminary results.
de Thé G; Ablashi DV; Liabeuf A; Mourali N
Biomedicine; 1973 Aug; 19(8):349-52. PubMed ID: 4359467
[No Abstract] [Full Text] [Related]
6. Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups.
Neel HB; Pearson GR; Taylor WF
Ann Otol Rhinol Laryngol; 1984; 93(5 Pt 1):477-82. PubMed ID: 6093669
[TBL] [Abstract][Full Text] [Related]
7. An immunologic basis for detection of occult primary malignancies of the head and neck.
Coates HL; Pearson GR; Neel HB; Weiland LH; Devine KD
Cancer; 1978 Mar; 41(3):912-8. PubMed ID: 205337
[TBL] [Abstract][Full Text] [Related]
8. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma].
Amador García JM; Mendoza Montero J; Expósito Hernández J; Salinero Hernández J; Esquivias López-Cuerpo J; Ballesteros García P
Acta Otorrinolaringol Esp; 1992; 43(1):31-6. PubMed ID: 1316136
[TBL] [Abstract][Full Text] [Related]
9. Presence of EBNA in nasopharyngeal carcinoma and control patient tissues related to EBV serology.
Huang DP; Ho HC; Henle W; Henle G; Saw D; Lui M
Int J Cancer; 1978 Sep; 22(3):266-74. PubMed ID: 212372
[No Abstract] [Full Text] [Related]
10. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus detection in neck metastases by polymerase chain reaction.
Walter MA; Menarguez-Palanca J; Peiper SC
Laryngoscope; 1992 May; 102(5):481-5. PubMed ID: 1315410
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus (EBV) antibody in patients treated by radical radiotherapy for head and neck cancer.
Halili MR; Spigland I; Foster N; Ghossein NA
J Surg Oncol; 1978; 10(5):457-63. PubMed ID: 215844
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology.
Faggioni A; Corradini C; Venanzoni M; Cardi G; Bevere F; Barile G; Zompetta C; Frati L
J Exp Pathol; 1987; 3(4):471-7. PubMed ID: 2842480
[TBL] [Abstract][Full Text] [Related]
14. Nasopharyngeal carcinoma and Epstein-Barr virus. I. Factors related to the anti-VCA antibody.
Lynn T; Tu S; Hirayama T; Kawamura A
Jpn J Exp Med; 1973 Apr; 43(2):121-33. PubMed ID: 4352111
[No Abstract] [Full Text] [Related]
15. [The involvement of RCAS1 in creating a suppressive tumor microenvironment in patients with pharyngeal squamous cell carcinoma].
Dutsch-Wicherek M; Windorbska W; Jóźwicki W; Kaźmierczak H
Otolaryngol Pol; 2012 Sep; 66(4 Suppl):49-59. PubMed ID: 23164108
[TBL] [Abstract][Full Text] [Related]
16. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
[TBL] [Abstract][Full Text] [Related]
17. Determination of nonendemic nasopharyngeal carcinoma by in situ hybridization for Epstein-Barr virus EBER1 RNA: sensitivity and specificity in cervical node metastases.
Dictor M; Sivén M; Tennvall J; Rambech E
Laryngoscope; 1995 Apr; 105(4 Pt 1):407-12. PubMed ID: 7536285
[TBL] [Abstract][Full Text] [Related]
18. Application of Epstein-Barr virus serology to the diagnosis and staging of North American patients with nasopharyngeal carcinoma.
Neel HB; Pearson GR; Weiland LH; Taylor WF; Goepfert HH; Pilch BZ; Goodman M; Lanier AP; Huang AT; Hyams VJ; Levine PH; Henle G; Henle W
Otolaryngol Head Neck Surg; 1983 Jun; 91(3):255-62. PubMed ID: 6308537
[TBL] [Abstract][Full Text] [Related]
19. Squamous cell carcinoma. Metastasis to the neck from an unknown or undiscovered primary.
DeSanto LW; Neel HB
Otolaryngol Clin North Am; 1985 Aug; 18(3):505-13. PubMed ID: 2995900
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus antibodies in Sudanese patients with nasopharyngeal carcinoma: a preliminary report.
Malik MO; Banatvala J; Hutt MS; Abu-Sin AY; Hidaytallah A; El-Hadi AE
J Natl Cancer Inst; 1979 Feb; 62(2):221-4. PubMed ID: 216831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
